Maxim Group Downgrades China-Biotics (CHBT) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq hits record high as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts CHBT Hot Sheet
Price: $2.60 --0%
Rating Summary:
0 Buy, 0 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 26
Rating Summary:
0 Buy, 0 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 26
Join SI Premium – FREE
Maxim Group downgraded China-Biotics (NASDAQ: CHBT) from Buy to Hold.
For more ratings news on China-Biotics click here and for the rating history of China-Biotics click here.
Shares of China-Biotics closed at $8.04 yesterday.
For more ratings news on China-Biotics click here and for the rating history of China-Biotics click here.
Shares of China-Biotics closed at $8.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Kubota Corp (6326:JP) (KUBTY) to Sell
- Evercore ISI Downgrades Align Technology (ALGN) to In Line
- Barclays Downgrades PTC Inc. (PTC) to Equalweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
